Last reviewed · How we verify
Phase II Study of Postoperative Adjuvant Immunotherapy and Radiation in Patients With Completely Resected Stage II and Stage IIIA Non-Small Cell Lung Cancer
RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining these two treatments may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining vaccine therapy with radiation therapy in treating patients who have stage II or stage IIIA non-small cell lung cancer that has been completely removed in surgery.
Details
| Lead sponsor | Radiation Therapy Oncology Group |
|---|---|
| Phase | Phase 2 |
| Status | COMPLETED |
| Start date | 2001-03 |
Conditions
- Lung Cancer
Interventions
- monoclonal antibody 11D10 anti-idiotype vaccine
- monoclonal antibody 3H1 anti-idiotype vaccine
- radiation therapy
Countries
United States, Canada